Maybe if you bought it at $4.50, but those who have been in this stock for two or three years think it's a definite gem.
We aren't going to be warned ahead of time about good or bad news, at least not early enough to buy more or get out. Only the big boys and girls get those tips.
No company, including this one, goes from 50 cents a share to $100 without a number of ups and downs, but there is nothing that indicates anything but good outcomes on our two main products, so I'm holding firm.
If I didn't think a big payday was coming, I would have sold at $4.70.
Could be, but it provides an occasional opportunity to buy more shares at bargain basement prices. I did this the last time at $3.16 and it went to $4.70 or so before starting back down. If you believe in the science of CUR, these ups and downs are great opportunities.
Sentiment: Strong Buy
Great hindsight, Pete! We can all say we shoulda-coulda about lots of stocks. CUR is volatile. We know that. Last time it dropped this low, I bought another 8,209 shares. I'm thinking about adding again.
It seems to me that NSI-189 is the real blockbuster of the future. I assume it will be a much less expensive treatment and applicable to multiple millions of Americans and others around the world. However, curing or at least radically slowing the progression of ALS should remain high on the company's agenda.
The lack of comment today on such a huge move up is puzzling. I've got 4,000 shares and wiped out a loss today with approximately a $9,000 gain in value.
Since they named a new marketing director and got Wells Fargo coverage, I've lost the $17,000 I was up on the stock. I can't take any more good news! :)
You would think if Fuel's strength is "intelligent targeting" that political advertising directly to registered and frequent voters would be its forte.